The present invention provides therapeutically active compounds and compositions as receptor antagonists and methods of use thereof. In one aspect, the compounds are useful in modulating pain, inflammation and acute phase reactions by inhibiting the PGE2 receptors including PGE2 EP1, EP2 and EP4 receptors.
Countries or Regions:
USA, UK, Hong Kong, China
Invention Code:
TTC.PA.1070
Contact Us:
okt@ust.hk